Biomarin Pharmaceutical Inc (NAS:BMRN)
$ 65.42 0.54 (0.83%) Market Cap: 12.47 Bil Enterprise Value: 12.14 Bil PE Ratio: 39.17 PB Ratio: 2.30 GF Score: 72/100

Biomarin Pharmaceutical Inc at SVB Securities Global Biopharma Conference (Virtual) Transcript

Feb 16, 2023 / 04:20PM GMT
Release Date Price: $107.29 (-0.82%)
Joseph Patrick Schwartz
SVB Securities LLC, Research Division - Senior MD of Rare Diseases & Senior Research Analyst

Hello. Welcome to this fireside chat with BioMarin Pharmaceuticals. I'm Joe Schwartz, Senior Equity Research Analyst at SVB Securities. It's my pleasure to be joined by management, including JJ Bienaime, Jeff Ajer and Brian Mueller. Thank you so much for joining us.

Maybe will start by having you, JJ, give us a quick rundown of the company's key initiatives and catalysts that we should look forward to over the balance of this year, and then we'll go to Q&A.

Jean;Jacques Bienaime
BioMarin Pharmaceutical Inc. - Chairman & CEO

Sounds good. Thank you, Joe, and good morning, everyone. Thank you for joining us today. As you know, we are less than 2 weeks away from our Q4 full year financial results call. So we would like to avoid specifics of the fourth quarter.

In January, we provided a high-level strategy and framework for growth of the company in the near term and by mid-decade and throughout the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot